Repeated courses of sequential venetoclax and donor lymphocyte infusions in a patient with relapsed high-risk myelodysplasia following allogeneic stem cell transplantation: a case report
BackgroundAllogeneic hematopoietic stem cell transplantation (allo-HSCT) represents the only potentially curative therapy in patients with high-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). However, a considerable proportion of …